Innovative inhaler: the Novolizer
On the global market
The Novolizer is now on sale on the global market and the number of asthma and COPD drugs for which it can be used will soon be increased. Various pharmaceutical companies are involved in its further development. In addition, De Boer and Frijlink and their team of specialists are currently working on a special disposable inhaler (the Twincer) for administering drugs for conditions such as cystic fibrosis and tuberculosis. The pharmaceutical industry is already keenly anticipating this new inhaler, as it is also suitable for administering flu jabs and vaccinations against various other infectious diseases. It is thought that the Twincer will be available for use by patients in just a few years.
On 21 April 2010, Anne de Boer and Erik Frijlink were awarded the Wubbo Ockels prize for the successful development of this innovative Novolizer inhaler.
Last modified: | 22 May 2018 10.35 a.m. |
More news
-
22 April 2024
Nine Marie Skłodowska-Curie Doctoral Networks for the University of Groningen
The University of Groningen achieved very good results in the previous round of the Marie Skłodowska-Curie Doctoral Networks. Nine of the 42 submissions have now been funded.
-
22 April 2024
Charissa Roossien secures JTF subsidy to develop Health Tracker
Dr. Charissa Roossien (ENTEG) has successfully secured a Just Transition Fund (JTF) subsidy of 1.8 million euros to develop a Health Tracker for reliable respiratory and metabolic analysis.
-
15 April 2024
Single-molecule engineering niche in Gravitation research
With her expertise in single-molecule techniques, Dr. Kasia Tych (GBB) will contribute to a big Grvitation-research programme